GlaxoSmithKline Pharmaceuticals Limited
NSE:GLAXO.NS
2698.35 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 34,531.835 | 32,517.2 | 32,780.292 | 31,988.622 | 32,243.807 | 31,281.188 | 28,714.53 | 29,084.688 | 27,635.013 | 26,384.208 | 25,547.637 | 26,542.747 | 23,784.762 | 21,510.561 | 19,077.689 | 16,934.08 | 16,082.056 | 15,819.897 | 15,185.366 | 14,096.776 |
| Cost of Revenue
| 21,716.979 | 12,848.7 | 14,496.539 | 13,946.729 | 13,975.445 | 14,445.266 | 13,278.41 | 14,817.314 | 13,334.336 | 12,255.834 | 12,293.207 | 11,569.495 | 9,193.307 | 7,881.474 | 7,021.813 | 6,557.838 | 6,366.452 | 6,314.875 | 6,389.513 | 6,035.152 |
| Gross Profit
| 12,814.856 | 19,668.5 | 18,283.753 | 18,041.893 | 18,268.362 | 16,835.922 | 15,436.12 | 14,267.374 | 14,300.677 | 14,128.374 | 13,254.43 | 14,973.252 | 14,591.455 | 13,629.087 | 12,055.876 | 10,376.242 | 9,715.604 | 9,505.022 | 8,795.853 | 8,061.624 |
| Gross Profit Ratio
| 0.371 | 0.605 | 0.558 | 0.564 | 0.567 | 0.538 | 0.538 | 0.491 | 0.517 | 0.535 | 0.519 | 0.564 | 0.613 | 0.634 | 0.632 | 0.613 | 0.604 | 0.601 | 0.579 | 0.572 |
| Reseach & Development Expenses
| 25.437 | 19.099 | 18.285 | 18.072 | 21.802 | 23.266 | 22.522 | 18.962 | 19.957 | 17.548 | 26.286 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 486.294 | 291.868 | 425.917 | 184.696 | 170.484 | 277.324 | 368.746 | 55.754 | 65.696 | 4,127.862 | 56.882 | 41.427 | 6,926.056 | 6,042.704 | 5,314.791 | 4,422.463 | 4,163.644 | 4,604.797 | 4,372.393 | 4,098.34 |
| Selling & Marketing Expenses
| 1,797.739 | 1,662.579 | 1,837.419 | 1,719.401 | 2,013.364 | 2,057.917 | 1,543.367 | 1,836.898 | 1,917.14 | 1,107.086 | 1,939.985 | 1,667.563 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 3,848.076 | 1,954.447 | 2,263.336 | 1,904.097 | 2,183.848 | 2,335.241 | 1,912.113 | 1,892.652 | 1,982.836 | 5,234.949 | 1,996.867 | 1,708.99 | 6,926.056 | 6,042.704 | 5,314.791 | 4,422.463 | 4,163.644 | 4,604.797 | 4,372.393 | 4,098.34 |
| Other Expenses
| -483.843 | 10,328.853 | 9,032.074 | 9,628.743 | 11,291.271 | 8,934.875 | 8,759.073 | 7.2 | 7.159 | 0 | 6.541 | 5,270.14 | -1,607.919 | -1,129.773 | -870.56 | -1,056.328 | -723.33 | -763.147 | -460.81 | -315.626 |
| Operating Expenses
| 4,357.356 | 12,283.3 | 11,295.41 | 11,532.84 | 13,475.119 | 11,270.116 | 10,671.186 | 10,341.031 | 9,659.946 | 9,666.982 | 8,058.11 | 6,979.13 | 5,318.137 | 4,912.931 | 4,444.231 | 3,366.135 | 3,440.314 | 3,841.65 | 3,911.583 | 3,782.714 |
| Operating Income
| 8,457.5 | 8,391.8 | 7,691.439 | 7,614.88 | 5,431.601 | 6,531.106 | 5,247.808 | 3,926.343 | 4,640.731 | 4,885.726 | 5,196.32 | 7,994.122 | 9,273.318 | 8,716.156 | 7,611.645 | 7,010.107 | 6,275.29 | 5,663.372 | 4,884.27 | 4,278.91 |
| Operating Income Ratio
| 0.245 | 0.258 | 0.235 | 0.238 | 0.168 | 0.209 | 0.183 | 0.135 | 0.168 | 0.185 | 0.203 | 0.301 | 0.39 | 0.405 | 0.399 | 0.414 | 0.39 | 0.358 | 0.322 | 0.304 |
| Total Other Income Expenses Net
| -295.621 | -27.8 | 99.042 | -2,109.897 | -2,374.07 | 295.587 | 151.844 | 1,185.516 | 1,153.959 | 1,159.725 | 1,918.186 | 349.49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| 8,161.879 | 8,364 | 7,790.481 | 5,504.983 | 3,057.531 | 6,826.693 | 5,399.652 | 5,111.859 | 5,794.69 | 6,045.45 | 7,114.506 | 8,343.612 | 9,273.318 | 8,716.156 | 7,611.645 | 7,010.107 | 6,275.29 | 5,663.372 | 4,884.27 | 4,278.91 |
| Income Before Tax Ratio
| 0.236 | 0.257 | 0.238 | 0.172 | 0.095 | 0.218 | 0.188 | 0.176 | 0.21 | 0.229 | 0.278 | 0.314 | 0.39 | 0.405 | 0.399 | 0.414 | 0.39 | 0.358 | 0.322 | 0.304 |
| Income Tax Expense
| 2,262.269 | 2,287.6 | 3,982.792 | 1,923.51 | 2,125.485 | 2,372.763 | 1,892.394 | 1,743.739 | 2,026.431 | 2,234.163 | 2,297.838 | 2,724.808 | 3,051.431 | 2,933.504 | 2,607.038 | 2,381.364 | 2,179.222 | 1,991.292 | 1,767.259 | 1,572.571 |
| Net Income
| 5,899.61 | 6,106.868 | 3,807.689 | 3,581.473 | 932.046 | 4,453.93 | 3,507.258 | 3,368.12 | 3,768.259 | 3,811.287 | 4,816.668 | 5,618.804 | 4,285.875 | 5,605.716 | 5,078.584 | 5,910.851 | 5,475.472 | 5,509.977 | 5,071.453 | 3,376.778 |
| Net Income Ratio
| 0.171 | 0.188 | 0.116 | 0.112 | 0.029 | 0.142 | 0.122 | 0.116 | 0.136 | 0.144 | 0.189 | 0.212 | 0.18 | 0.261 | 0.266 | 0.349 | 0.34 | 0.348 | 0.334 | 0.24 |
| EPS
| 34.83 | 36.05 | 22.48 | 21.14 | 5.5 | 26.29 | 20.7 | 19.88 | 22.21 | 22.5 | 28.44 | 33.17 | 25.3 | 33.09 | 29.98 | 34.89 | 32.32 | 32.53 | 29.55 | 19.34 |
| EPS Diluted
| 34.83 | 36.05 | 22.48 | 21.14 | 5.5 | 26.29 | 20.7 | 19.88 | 22.21 | 22.5 | 28.44 | 33.17 | 25.3 | 33.09 | 29.98 | 34.89 | 32.32 | 32.53 | 29.55 | 19.34 |
| EBITDA
| 9,152.858 | 9,049.5 | 8,373.299 | 8,407.716 | 6,258.378 | 7,017.013 | 5,627.666 | 4,918.098 | 6,017.829 | 5,088.546 | 7,052.961 | 9,872.321 | 11,484.953 | 9,069.374 | 7,701.354 | 5,891.364 | 5,101.254 | 4,026.238 | 3,129.659 | 3,825.713 |
| EBITDA Ratio
| 0.265 | 0.278 | 0.255 | 0.263 | 0.194 | 0.224 | 0.196 | 0.169 | 0.218 | 0.193 | 0.276 | 0.372 | 0.483 | 0.422 | 0.404 | 0.348 | 0.317 | 0.255 | 0.206 | 0.271 |